ID
34809
Description
TEST StudyStudy ID: 102863 Clinical Study ID: 102863 Study Title: A randomized, open-label, two-period, period-balanced, crossover study with three parallel groups to evaluate the relative bioavailability of single oral doses of SB 497115-GR phase III tablets [50 mg, 75 mg, 100 mg] compared to SB-497115-GR phase II tablets [25 mg and 50 mg] in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Trade Name: Eltrombopag Study Indication: Thrombocytopenia
Mots-clés
Versions (1)
- 30/01/2019 30/01/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
30 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Relative Bioavailability of SB 497115-GR phase III tablets compared to SB-497115-GR phase II tablets 102863
PGx-Pharmacogenetic Research Form
- StudyEvent: ODM
Description
Consent for PGx-Pharmacogenetic Research
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0021430
Description
Pharmacogenetic Test, Informed Consent
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
Description
Pharmacogenetic Test, Informed Consent, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0011008
Description
Pharmacogenetic Test, Informed Consent, Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C0031325
- UMLS CUI [1,2]
- C0021430
- UMLS CUI [1,3]
- C0392360
Description
Blood Sample Collection (DNA)
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0005834
- UMLS CUI-3
- C0012854
Description
Pharmacogenetic Tests, Collection of blood specimen for laboratory procedure
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0005834
Description
Pharmacogenetic Tests, Collection of blood specimen for laboratory procedure, Date in time
Type de données
date
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0005834
- UMLS CUI [1,3]
- C0011008
Description
Withdrawal of Consent
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C1707492
Description
Blood Sample Destruction
Alias
- UMLS CUI-1
- C2347500
- UMLS CUI-2
- C0178913
- UMLS CUI-3
- C1948029
Description
Pharmacogenetic Test, Blood Specimen, Destruction, Request
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C1272683
Description
Pharmacogenetic Test, Blood Specimen, Destruction, Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347500
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1948029
- UMLS CUI [1,4]
- C3146298
Similar models
PGx-Pharmacogenetic Research Form
- StudyEvent: ODM
C0021430 (UMLS CUI-2)
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0005834 (UMLS CUI-2)
C0012854 (UMLS CUI-3)
C0005834 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C1707492 (UMLS CUI-2)
C1707492 (UMLS CUI [1,2])
C0178913 (UMLS CUI-2)
C1948029 (UMLS CUI-3)
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,4])
Aucun commentaire